August 27, 2013
Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration clearance and launch of the BD ProbeTec™ Trichomonas vaginalis Qx Amplified DNA Assay for the direct qualitative detection of T. vaginalis DNA in endocervical and vaginal [...]
Protea Announces Expansion of Patent Portfolio
August 27, 2013
Morgantown, WV; Zrotea Biosciences Group, Inc. (“Protea”) announced today that the George Washington University has been awarded two additional patents for its LAESI technology platform, for which Protea is the exclusive licensee. The first patent is titled “Laser Ablation Electrospray Ionization (LAESI) for Atmospheric Pressure, In Vivo, and Imaging Mass Spectrometry” (U.S. Patent #8,487,244) and [...]
August 27, 2013
Spartan Bioscience today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance permitting marketing of the Spartan RX CYP2C19 System. It provides genetic results in less than 60 minutes from a non-invasive cheek swab. The automated system is indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by [...]
RUCDR Infinite Biologics Selects NuGEN as Corporate Sponsor and Genomic Sample Processing Partner
August 27, 2013
RUCDR Infinite Biologics, the world’s largest university-based biorepository, has added NuGEN Technologies to its group of technology sponsors. A unit of Rutgers, The State University of New Jersey, RUCDR Infinite Biologics currently stores more than 12 million biosamples. Dr. Andy Brooks, chief operating officer of RUCDR Infinite Biologics, said: “The RUCDR corporate sponsorship program is [...]
August 27, 2013
AB SCIEX, a global leader in analytical technologies, today announced the launch of MasterViewTM Software, a new software application with built-in automation that quickly turns enormous amounts of complex analytical data into simplified, meaningful answers for safer food, cleaner environments and more reliable forensic drug screening than alternative approaches. Designed for both targeted and non-targeted [...]
XY Stages for High Speed Microscopy Applications
August 27, 2013
IntelLiDrives introduced Open Frame XY stages designed to replace manual stages found on the microscopes to provide motorized XY positioning of microscopy samples. These motorized stages enable scanning speeds of 10 mm/s. The linear feedback ensures correct positioning with a resolution of 0.1 µm and repeatability of 0.25 µm, while user programmable motion profiles allows [...]
August 27, 2013
Medford, – Hepregen Corporation, developer of next generation HepatoPacTM and HepatoMuneTM products, announced today the commercial launch of the Company’s first applicationoriented Human HepatoPacTM Kit designed specifically for use in metabolite identification and profiling. The DMPK Kit, first of its kind, was developed over a 5-year period with significant input from Hepregen’s pharmaceutical company customers [...]
August 27, 2013
CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE) today announced the first end-to-end sequencing solution for exon-level copy number variation (CNV) analysis, which combines the Ion Reporter™ CNV data analysis workflow, the Ion AmpliSeq™ Exome Kit and the Ion Proton® System. Inherited and de novo CNVs of chromosomal regions, in which large regions ( > [...]
Waters Corporation Announces CEO Transition Plan
August 27, 2013
MILFORD, Mass.-- Waters Corporation (NYSE/WAT) today announced that Douglas A. Berthiaume has communicated his intention to retire as Chief Executive Officer of the Company within the next twenty-four months. The Board of Directors has appointed a Succession Planning Committee that will guide the process of selecting a successor, and plans to engage an executive search [...]
August 27, 2013
London UK - Desktop Genetics Ltd (DeskGen), a UK bioinformatics company aiming to revolutionize the way genetic engineers work together, announced today that it has secured an equity investment of £275,000. The investment comes from Boundary Capital Ltd, Execute Technologies Inc, and angel investors Richard Youngman, Michael Martin (both of Anvil Partners LLP), Dr Jonathan [...]
